ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Patrick Burnett sold $637K of Arcutis Biotherapeutics, Inc.
Sold$636,706
$8.73Price
72,952Shares
−26%Stake
What ARQT did after the filing
- The stock from Mon, Jun 3 open, $8.40
- +22.3%
- S&P 500, same days
- +5.6%
Measured over 30 trading days, to the Jul 17 close.
Traded Wed, May 29. Filed Fri, May 31, 4:50 PM ET, after the close. Returns use the Jun 3 open and the Jul 17 close. Not investment advice.